Assure Announces it will Remain Listed on the Nasdaq Capital Market Pursuant to Nasdaq Panel Decision
DENVER, May 16, 2024 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ:IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today it received a written notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that it has granted the Company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market (the “Panel Decision”). The Hearings Panel granted the Company an extension until July 22, 2024, by which date the Company will be required to demonstrate compliance with all applicable initial listing requirements for the Nasdaq Capital Market in relation to its completion of its previously announced transaction with Danam Health Inc.
Related news for (IONM)
- Assure Announces Extension of Exchange Offer Relating to its Convertible Notes
- Assure Announces Reverse Stock Split to support Continued Listing on NASDAQ
- SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate AKLI, WIRE, CBNK, IONM
- Assure Holdings Receives Notification of Delinquency from Nasdaq
- Assure & Danam Reschedule Corporate Update Call & Webcast